07:00 , Aug 6, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Fascin 1 actin-bundling protein (FSCN1)

Cancer INDICATION: Cancer In vitro and mouse studies suggest inhibiting FSCN1 activity could help prevent or treat metastatic cancers. In an in vitro actin-bundling assay, high throughput screening identified a compound that inhibited FSCN1-mediated actin...
07:00 , Jul 28, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Acid phosphatase 5 tartrate resistant (ACP5); fascin homolog 1 actin-bundling protein (FSCN1); homeobox A1 (HOXA1); heat shock transcription factor 1 (HSF1); NDC80 homolog kinetochore...
07:00 , Apr 22, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

-Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Fascin homolog 1, actin-bundling protein (FSCN1) In vitro, mouse and human studies suggest that inhibiting FSCN1 could help prevent tumor metastasis. In vitro, the...